Patent · US Active

Dosage forms containing terbutaline sulphate

US9849097B2 · kind B2 · utility

3Cited by

0References

27Claims

0Family size

Assignee

JAGOTEC AG · CH

Inventors

Alain Nhamias · Bartenheim, FR
Nasser Beniou · Mulhouse, FR

Key dates

Filing date	Oct 8, 2013
Grant date	Dec 26, 2017
Priority date	—
Expiry date	Oct 8, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/2813
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A modified release oral dosage form comprising an internal phase containing terbutaline sulphate and a pharmaceutically acceptable excipient, dispersed in an external phase comprising pharmaceutically acceptable excipients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.